MarylandSB 04352026 Regular SessionSenate

Public Health - Medetomidine and Xylazine Consumer Protection Act

Sponsored By: William G. Folden (Republican)

Passed

Public HealthAge -see also- Age of Maj; Children; Elderly; Inf&Tod.; etcComptrollerConsumer ProtectionControlled Dangerous Substances -see also- Drugs; OpioidsDrugs -see also- Cannabis; ControlDangSubst; Pharm; etc.Health -see also- COVID19; EnvHlth; MedCon; etc.Health, Department ofIdentification -see also- Biometrics; Fingerprinting; DrLicsPenalties and Sentences -see also- Death PenaltyRecords -see also- Land Records; Vital RecordsRetail SalesRevenue and Taxes -see also- (specific tax)Rules and RegulationsScientific Research -see also- ChemTst; MedRsrch; StudiesSubstance AbuseVeterinariansWholesale Distribution

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • William G. Folden

    Republican • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Motion Laid Over (Senator Ready) Adopted

    4/13/2026Senate
  2. Favorable with Amendments {983727/1

    4/13/2026Senate
  3. Favorable with Amendments Report by Finance

    4/13/2026Senate
  4. Hearing 2/11 at 2:00 p.m.

    2/3/2026Senate
  5. First Reading Finance

    1/30/2026Senate

Bill Text

  • First Reading

    1/30/2026

Related Bills

Back to State Legislation